APA (7th ed.) Citation

Vay, M., Meyer, M. J., Blank, A., Skopp, G., Rose, P., Tzvetkov, M. V., & Mikus, G. (2020). Oral yohimbine as a new probe drug to predict CYP2D6 activity: Results of a fixed-sequence phase I trial. Clinical pharmacokinetics, 59(7), . https://doi.org/10.1007/s40262-020-00862-6

Chicago Style (17th ed.) Citation

Vay, Manuela, Marleen J. Meyer, Antje Blank, Gisela Skopp, Peter Rose, Mladen Vassilev Tzvetkov, and Gerd Mikus. "Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-sequence Phase I Trial." Clinical Pharmacokinetics 59, no. 7 (2020). https://doi.org/10.1007/s40262-020-00862-6.

MLA (9th ed.) Citation

Vay, Manuela, et al. "Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-sequence Phase I Trial." Clinical Pharmacokinetics, vol. 59, no. 7, 2020, https://doi.org/10.1007/s40262-020-00862-6.